BLPH insider filings
Bellerophon Therapeutics, Inc. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-16. Screen BLPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BLPH between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Bellerophon Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-10-16 | 4 | Puissance Capital Management LP — 10% owner Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Wang Theodore T — 10% owner | Sale (S): 1,076,841 @ $0.10 | EDGAR |
| 2023-06-09 | 4 | Amin Naseem — Director | Grant/award (A): 47,578 @ $0 | EDGAR |
| 2023-06-09 | 4 | Fernandes Peter — See Remarks | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Shah Parag Suresh — VP of Business Operations | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Dekker Martin — See Remarks | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Kim Bobae — VP Reg. Affairs & Quality | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Wang Theodore T — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Cloyd Mary Ann — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Teufel Crispin — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Bruder Scott P — Director | Grant/award (A): 14,607 (derivative) @ $0 | EDGAR |
| 2023-06-07 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Puissance Capital Management LP — 10% owner Wang Theodore T — Director, 10% owner | Sale (S): 134,421 @ $0.83 | EDGAR |
| 2023-05-22 | 4 | Kim Bobae — VP Reg. Affairs & Quality | Option exercise (M): 266 @ $7.35 · Option exercise (M): 1,022 @ $7.50 · Sale (S): 9,455 @ $10 · Option exercise (M): 266 (derivative) @ $0 · Option exercise (M): 1,022 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Puissance Life Science Opportunities Fund VI — 10% owner Puissance Capital Fund (GP) LLC — 10% owner Wang Theodore T — Director, 10% owner Puissance Capital Management LP — 10% owner | Sale (S): 560,000 @ $9.46 | EDGAR |
Recent 8-K events — Bellerophon Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2024-01-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-12-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-11-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-10-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-08-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-07-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BLPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →